• Dr. Reddy's Laboratories appointed Akhil Ravi head of API and services, effective November 13, 2026.
• Ravi will join senior management and become a member of the management council.
• Currently CEO of subsidiary Aurigene Pharmaceutical Services, Ravi joined in 2018 and brings nearly 19 years of professional experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000724), on October 23, 2026, and is solely responsible for the information contained therein.